BioPhorum member only benchmarking exercise seeking member experience on expectations for mycoplasma testing of cell therapies.
cell therapy
Viewing related articles
read more
Visual inspection of drug product bag for Phase I/II CT program
Oct 2022 | Annex 1, Benchmarking, Cell & Gene Therapy, Commercialization, Deliverable, Deliverables Report
A BioPhorum member only survey, the goal of which is to understand what the current industry standard is for visual inspection of final drug product bag for Phase I/II autologous/allogeneic cell therapy programs.